#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Cefprozil in the Treatment of Patients with Exacerbation of Chronic Obstructive PulmonaryDisease (COPD)


Authors: J. Musil 1;  O. Lochmann 2;  B. Horová 3;  J. Dindoš 4;  P. Lisá 5;  O. Herber 6;  Š. Čermáková 7;  J. Jedlička 8
Authors‘ workplace: Radiodiagnostické oddělení 1Subkatedra tuberkulózy a respiračních nemocí IPVZ, Praha 2Ústav mikrobiologie 2. LF UK, Praha 3Odd. klinické mikrobiologie FN Bulovka, Praha 4Pneumolog, Neratovice 5Ambulantní oddělení tuberkulózy a respiračních nemocí, Praha 7
Published in: Prakt. Lék. 2002; (8): 490-494
Category:

Overview

To test the effectiveness of cefprozil an open multi-centre trial was made which comprised 52patients with exacerbation of COPD. The patients were subjected to clinical examination,spirometry, blood samples were taken to assess thenumber of leukocytes. Sputumwas subjectedto bacteriological examination.38 patients (73%) were cured, 13 (25%) improved. Treatment failed in 1 (2%).The most frequent undesirable effect was allergy which was recorded in 2 (4%) patients.

Key words:
cefprozil - treatment - exacerbation of chronic obstructive pulmonary disease.

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
General practitioner for children and adolescents General practitioner for adults
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#